Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease
- PMID: 18020970
- DOI: 10.1515/CCLM.2007.358
Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease
Abstract
Hyperhomocysteinemia (HHcy) is a significant and independent risk factor for cardiovascular disease (CVD) and the underlying mechanism is unclear. We and others have reported that homocysteine (Hcy) is inversely correlated with plasma high-density lipoprotein cholesterol (HDL-C) and apolipoprotein AI (apoA-I) in patients with coronary heart disease (CHD). We confirmed this negative correlation in mice with targeted deletions of the genes for apolipoprotein E (apoE) and cystathionine beta-synthase (CBS). Severe HHcy (plasma Hcy 210 micromol/L) accelerates spontaneous arthrosclerosis in the CBS(-/-)/apoE(-/-) mice, reduces the concentration of circulating HDL, apoA-I, and large HDL particles, inhibits HDL function, and enhances HDL-C clearance. We have demonstrated further that Hcy (0.5-2 mmol/L) reduces apoA-I protein synthesis and secretion, but not RNA transcription in mouse primary hepatocytes. A different mechanism was proposed based on studies using the HepG2 cells showing that Hcy (5-10 mmol/L) inhibits apoA-I transcription via peroxisome proliferator-activated receptor-alpha (PPARalpha)-inhibition-dependent and -independent mechanisms. These studies suggest that Hcy-induced HDL-C and apoA-I inhibition represent a novel mechanism by which Hcy induces atherosclerotic CVD.
Similar articles
-
Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance.Circ Res. 2006 Sep 15;99(6):598-606. doi: 10.1161/01.RES.0000242559.42077.22. Epub 2006 Aug 24. Circ Res. 2006. PMID: 16931800 Free PMC article.
-
Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease.Circ Res. 2006 Mar 3;98(4):564-71. doi: 10.1161/01.RES.0000204825.66410.0b. Epub 2006 Jan 26. Circ Res. 2006. PMID: 16439690
-
Homocysteine diminishes apolipoprotein A-I function and expression in patients with hypothyroidism: a cross-sectional study.Lipids Health Dis. 2016 Jul 26;15:123. doi: 10.1186/s12944-016-0293-5. Lipids Health Dis. 2016. PMID: 27457726 Free PMC article.
-
Hyperhomocysteinemia and atherosclerosis.Sheng Li Xue Bao. 2005 Apr 25;57(2):103-14. Sheng Li Xue Bao. 2005. PMID: 15830093 Review.
-
Hyperhomocysteinemia: a biochemical link between bone and cardiovascular system diseases?J Endocrinol Invest. 2009;32(4 Suppl):10-4. J Endocrinol Invest. 2009. PMID: 19724160 Review.
Cited by
-
Cardiovascular repercussions of the pseudoexfoliation syndrome.N Am J Med Sci. 2013 Aug;5(8):454-9. doi: 10.4103/1947-2714.117294. N Am J Med Sci. 2013. PMID: 24083219 Free PMC article. Review.
-
Serum homocysteine in Indian adolescents.Indian J Pediatr. 2009 Jul;76(7):705-9. doi: 10.1007/s12098-009-0116-z. Epub 2009 Apr 16. Indian J Pediatr. 2009. PMID: 19381504
-
Gene interactions observed with the HDL-c blood lipid, intakes of protein, sugar and biotin in relation to circulating homocysteine concentrations in a group of black South Africans.Mol Genet Metab Rep. 2019 Dec 26;22:100556. doi: 10.1016/j.ymgmr.2019.100556. eCollection 2020 Mar. Mol Genet Metab Rep. 2019. PMID: 31908954 Free PMC article.
-
High levels of homocysteine downregulate apolipoprotein E expression via nuclear factor kappa B.World J Biol Chem. 2016 Feb 26;7(1):178-87. doi: 10.4331/wjbc.v7.i1.178. World J Biol Chem. 2016. PMID: 26981206 Free PMC article.
-
Reversal of Lipid Metabolism Dysregulation by Selenium and Folic Acid Co-Supplementation to Mitigate Pathology in Alzheimer's Disease.Antioxidants (Basel). 2022 Apr 24;11(5):829. doi: 10.3390/antiox11050829. Antioxidants (Basel). 2022. PMID: 35624693 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
